UK Clinical Trial Confirms SaNOtize’s Breakthrough Treatment for COVID-19
Patients with a self-administered nasal spray application found to have reduced SARS-CoV-2 log viral load by more than 95% in...
Cures
Dexamethasone – ‘The Savior Drug’ for severe COVID-19 patients
"Dexamethasone reduces death in hospitalised patients with severe respiratory complications of COVID-19" Source: University of Oxford In March 2020, the...
Census of viral spike protein antigens reveals candidates for use in a COVID-19 vaccine
"The authors observed that antibodies from animals immunized with the receptor-binding domain the S1 domain, or the S1+S2 ectodomain neutralized...
Anti-viral coating developed by Indian scientists to prevent surface transmission of virus
"The molecules developed have an ability to chemically cross-link with different surfaces upon UV irradiation." Source: Department of Science and...
Oxford COVID-19 vaccine to begin phase II/III human trials
"University of Oxford researchers have begun recruiting for the next phase in human trials of a COVID-19 vaccine in human...
Antibody blocks infection by the SARS-CoV-2 in cells, scientists discover
"A fully human monoclonal antibody has been identified that prevents the SARS-CoV-2 (COVID-19) virus from infecting cultured cells." Source: Utrecht...
Statistical approach to COVID-19 clinical trials aims to accelerate drug approval process
"New methods for accelerating drug approvals during pandemics and for providing more accurate measures of the probabilities of success for...
Brazilian startup develops technology for monitoring of patients with suspected COVID-19
"Based on the Internet of Things, the system was developed in a project supported by FAPESP. Patients can be advised...
A cross-neutralizing monoclonal human antibody developed against SARS-CoV2
"Researchers at Utrecht University, Erasmus Medical Center and Harbour BioMed (HBM) reported that they have identified a fully human monoclonal...
Dynamic Immune Responses of COVID-19 Patients
"A sample of the COVID-19 virus that was cultured in the Duke-NUS containment laboratory." Source: Duke-NUS Medical School News Immune...
Oxford COVID-19 Vaccine Trial Explained!
"University of Oxford researchers have begun testing a COVID-19 vaccine in human volunteers in Oxford today. Around 1,110 people will...
Gilead’s antiviral drug, Remdesivir proves hopeful in Phase 3 trial
"Study Demonstrates Similar Efficacy with 5- and 10-Day Dosing Durations of Remdesivir" Source: Gilead's News Gilead Sciences, Inc. (Nasdaq: GILD)...